Paresthesia of mucosae membranes of an oral cavity against the background of taking inhaled hormonal drugs

Bronchial asthma draws the attention of increasing number of doctors worldwide. The prevalence of this disease is from 4 to 10%. Nowadays basic medicines for treatment and control of bronchial asthma are inhalation hormonal drugs which are taken daily and for a long time, often the whole life of a patient. According to numerous literary data, this drug group owing to a way of their introduction causes a series of complications in an oral cavity. The most frequent of them are the oropharyngeal candidiasis, a dysphonia and paresthesia of a mucosa of a mouth. Above-mentioned complications are directly bound to the existence of a dysbiosis of a mouth that contributes to the development of an immune failure and sensitivity to organism microbial antigens. It was established, that patients with bronchial asthma of medium-weight severity with various experience of intake of inhalation hormonal drugs were examined highly often complaint to dryness, a burning sensation not only in an oral cavity, but also in the field of a larynx and a pharynx, on a food faddism, pain at meal, on availability of scurf of white color on various sites of a mucosa of an oral cavity. There were not only existence of characteristic symptoms of these diseases, but also depression of the immunologic status and change of a microbial landscape of an oral cavity at the patients with bronchial asthma taking the inhalation hormonal drugs. The above confirms the fact of obligatory detailed studying of implications in an oral cavity at the patients with bronchial asthma taking the inhalation hormonal drugs and the related complications, their nature, and further development of a rational way of the etiopathogenetic scheme of treatment and also their prevention.

paresthesia of an oral cavity mucosa, oropharyngeal candidiasis, dysphonia, bronchial asthma, inhalation hormonal drugsimmunological status, microbial landscape